Suzanne L. Tomchuck, Ph.D. - Publications

2010 Biomedical Sciences Tulane University, New Orleans, LA, United States 
Cell Biology, Microbiology Biology, Immunology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kreisman NR, Wooliscroft LB, Campbell CF, Dotiwala AK, Cox ML, Denson AC, Betancourt AM, Tomchuck SL. Preconditioning Hippocampal Slices with Hypothermia Promotes Rapid Tolerance to Hypoxic Depolarization and Swelling: Mediation by Erythropoietin. Brain Research. 146517. PMID 31634451 DOI: 10.1016/j.brainres.2019.146517  0.44
2015 Tomchuck SL, Leung WH, Dallas MH. Enhanced cytotoxic function of natural killer and CD3+CD56+ cells in cord blood after culture. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 39-49. PMID 25464114 DOI: 10.1016/j.bbmt.2014.10.014  0.44
2012 Tomchuck SL, Norton EB, Garry RF, Bunnell BA, Morris CA, Freytag LC, Clements JD. Mesenchymal stem cells as a novel vaccine platform. Frontiers in Cellular and Infection Microbiology. 2: 140. PMID 23162801 DOI: 10.3389/Fcimb.2012.00140  0.44
2012 Tomchuck SL, Henkle SL, Coffelt SB, Betancourt AM. Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells. Plos One. 7: e39592. PMID 22745793 DOI: 10.1371/journal.pone.0039592  0.44
2010 Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. Plos One. 5: e10088. PMID 20436665 DOI: 10.1371/journal.pone.0010088  0.44
2009 Coffelt SB, Tomchuck SL, Zwezdaryk KJ, Danka ES, Scandurro AB. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Molecular Cancer Research : McR. 7: 907-15. PMID 19491199 DOI: 10.1158/1541-7786.MCR-08-0326  0.44
2009 Coffelt SB, Marini FC, Watson K, Zwezdaryk KJ, Dembinski JL, LaMarca HL, Tomchuck SL, Honer zu Bentrup K, Danka ES, Henkle SL, Scandurro AB. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 3806-11. PMID 19234121 DOI: 10.1073/Pnas.0900244106  0.44
2008 Coffelt SB, Waterman RS, Florez L, Höner zu Bentrup K, Zwezdaryk KJ, Tomchuck SL, LaMarca HL, Danka ES, Morris CA, Scandurro AB. Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. International Journal of Cancer. Journal International Du Cancer. 122: 1030-9. PMID 17960624 DOI: 10.1002/Ijc.23186  0.44
2008 Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells (Dayton, Ohio). 26: 99-107. PMID 17916800 DOI: 10.1634/stemcells.2007-0563  0.44
2006 Duong BN, Elliott S, Frigo DE, Melnik LI, Vanhoy L, Tomchuck S, Lebeau HP, David O, Beckman BS, Alam J, Bratton MR, McLachlan JA, Burow ME. AKT regulation of estrogen receptor beta transcriptional activity in breast cancer. Cancer Research. 66: 8373-81. PMID 16951146 DOI: 10.1158/0008-5472.Can-05-3845  0.44
Show low-probability matches.